Biodexa Pharmaceuticals (BDRX) Balance Sheet: Assets & Liabilities

Biodexa Pharmaceuticals (BDRX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Biodexa Pharmaceuticals reported total assets of GBP 18.18M and total liabilities of GBP 6.77M. Shareholders' equity was GBP 11.40M, up 37.0% from GBP 8.32M a year earlier. Total debt stood at GBP 61.00K against GBP 8.53M in cash and short-term investments, a net cash position of GBP 8.47M. That puts debt-to-equity at 0.01, compared with 0.09 a year earlier.

Biodexa Pharmaceuticals Balance Sheet Analysis

Values in billions GBP

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Biodexa Pharmaceuticals Plc (BDRX) - Annual data in billions GBP
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	0.01	0.00	0.01	0.00	0.01	0.01	0.01	0.00	0.01
Cash & Short-Term Investments	0.01	0.00	0.01	0.00	0.01	0.01	0.01	0.00	0.01
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	0.01	0.01	0.01	0.00	0.01	0.01	0.01	0.01	0.02
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Intangible Assets	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.01	0.01	0.00	0.00	0.00	0.00	0.02	0.01	0.03
Total Assets	0.02	0.01	0.01	0.01	0.01	0.01	0.03	0.02	0.05
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Accrued Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Total Current Liabilities	0.01	0.01	0.01	0.00	0.00	0.00	0.01	0.00	0.01
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01
Total Liabilities	0.01	0.01	0.01	0.00	0.00	0.00	0.01	0.00	0.01
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-0.16	-0.15	-0.14	-0.14	-0.13	-0.12	-0.10	-0.09	-0.07
Accumulated Other Comprehensive Income	0.05	0.05	0.06	0.05	0.05	0.05	0.05	0.05	0.06
Additional Paid-in Capital	0.10	0.10	0.09	0.09	0.09	0.07	0.07	0.05	0.05
Shares Outstanding	225.82	6.69	1.19	0.01	0.00	-	-	-	-
Total Stockholders' Equity	0.01	0.01	0.00	0.00	0.01	0.01	0.02	0.02	0.03
Total Liabilities & Equity	0.02	0.01	0.01	0.01	0.01	0.01	0.03	0.02	0.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biodexa Pharmaceuticals Balance Sheet

How much debt does Biodexa Pharmaceuticals have?

Biodexa Pharmaceuticals had total debt of GBP 61.00K as of Dec 31, 2025, against GBP 8.53M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was GBP 727.00K a year earlier.

What are Biodexa Pharmaceuticals's total assets?

Biodexa Pharmaceuticals reported total assets of GBP 18.18M as of Dec 31, 2025, up 23.0% from GBP 14.78M a year earlier. Total liabilities were GBP 6.77M.

What is Biodexa Pharmaceuticals's shareholders' equity?

Biodexa Pharmaceuticals's shareholders' equity was GBP 11.40M as of Dec 31, 2025, or about GBP 0.00 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition